Page last updated: 2024-09-05

erlotinib hydrochloride and Hemoptysis

erlotinib hydrochloride has been researched along with Hemoptysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Long, J; Thotathil, Z	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Hemoptysis

Article	Year
Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:9 Topics: Biopsy; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Follow-Up Studies; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Radiography, Thoracic	2007

Article

Year

Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:9

Topics: Biopsy; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Follow-Up Studies; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Radiography, Thoracic

2007